135 related articles for article (PubMed ID: 1782120)
1. Urinary vanilmandelic acid and homovanillic acid: markers of two distinct cell populations in neuroblastoma?
Mastrangelo R; Lasorella A; Iavarone A; Troncone L
Pediatr Hematol Oncol; 1991; 8(4):379-81. PubMed ID: 1782120
[No Abstract] [Full Text] [Related]
2. Measurement of urinary vanillylmandelic acid (VMA) and homovanillic acid (HVA) for diagnosis of neural crest tumors.
Sawada T
Pediatr Hematol Oncol; 1997; 14(4):291-3. PubMed ID: 9211532
[No Abstract] [Full Text] [Related]
3. [Characteristics of urinary excretion of vanilmandelic and homovanillic acids in cases of neuroblastoma during therapy].
Lamedica G; Falcone R; De Bernardi B; Canini S
Minerva Pediatr; 1978 Jan; 30(2):137-46. PubMed ID: 642879
[No Abstract] [Full Text] [Related]
4. Mass screening for neuroblastoma in Miyagi Prefecture.
Itano M; Morita S; Fujie H; Ohashi Y; Minegishi N; Minegishi M; Yamaguchi Y; Sato T; Tsuchiya S; Konno T
Tohoku J Exp Med; 1992 Oct; 168(2):137-9. PubMed ID: 1306297
[TBL] [Abstract][Full Text] [Related]
5. Stage and urinary catecholamine metabolite excretion in neuroblastoma. European Neuroblastoma Study Group.
Pritchard J; Barnes J; Germond S; Hartman O; de Kraker J; Lewis I; Lockwood L; Wallendszus K
Lancet; 1989 Aug; 2(8661):514-5. PubMed ID: 2570230
[No Abstract] [Full Text] [Related]
6. Urinary levels of vanilmandelic acid and homovanillic acid determined by high-speed liquid chromatography.
Yoshida A; Yoshioka M; Yamazaki T; Sakai T; Tamura Z
Clin Chim Acta; 1976 Dec; 73(2):315-20. PubMed ID: 1000851
[TBL] [Abstract][Full Text] [Related]
7. Clinical validation of urine 3-methoxytyramine as a biomarker of neuroblastoma and comparison with other catecholamine-related biomarkers.
Lam L; Woollard GA; Teague L; Davidson JS
Ann Clin Biochem; 2017 Mar; 54(2):264-272. PubMed ID: 27235704
[TBL] [Abstract][Full Text] [Related]
8. Interchangeability between 24-hour collection and single spot urines for vanillylmandelic and homovanillic acid levels in the diagnosis of neuroblastoma.
Cangemi G; Barco S; Reggiardo G; Viscardi E; Di Cataldo A; Garaventa A; Melioli G; Conte M
Pediatr Blood Cancer; 2013 Dec; 60(12):E170-2. PubMed ID: 23813598
[TBL] [Abstract][Full Text] [Related]
9. Excretion of octopamine metabolites in neuroblastoma.
Couch MW; Greer DM; Williams CM
Clin Chim Acta; 1986 Jul; 158(1):109-14. PubMed ID: 3091293
[TBL] [Abstract][Full Text] [Related]
10. [Vanillylmandelic acid (VMA) and homovanillic acid (HVA)].
Kanesaka Y; Tomita K
Nihon Rinsho; 1999 Dec; 57 Suppl():223-5. PubMed ID: 10778106
[No Abstract] [Full Text] [Related]
11. Assessment of the diurnal variations in urinary homovanillic and vanillylmandelic acid excretion for the diagnosis and follow-up of patients with neuroblastoma.
Tuchman M; Robison LL; Maynard RC; Ramnaraine ML; Krivit W
Clin Biochem; 1985 Jun; 18(3):176-9. PubMed ID: 4039636
[TBL] [Abstract][Full Text] [Related]
12. Mass screening for neuroblastoma in Japan.
Sawada T; Sugimoto T; Kawakatsu H; Matsumura T; Matsuda Y
Pediatr Hematol Oncol; 1991; 8(2):93-109. PubMed ID: 1863547
[TBL] [Abstract][Full Text] [Related]
13. Urinary 3-methoxy-4-hydroxyphenylacetic (homovanillic) and 3-methoxy-4-hydroxymandelic (vanillylmandelic) acids: gas-liquid chromatographic methods and experience with 13 cases of neuroblastoma.
Brewster MA; Berry DH; Moriarty M
Clin Chem; 1977 Dec; 23(12):2247-9. PubMed ID: 923075
[TBL] [Abstract][Full Text] [Related]
14. Method of measurement of urinary homovanillic acid and vanillylmandelic acid by gas chromatography-mass spectrometry suitable for neuroblastoma screening.
Seviour JA; McGill AC; Dale G; Craft AW
J Chromatogr; 1988 Nov; 432():273-7. PubMed ID: 3220894
[No Abstract] [Full Text] [Related]
15. Urinary excretion of 3-methoxy-4-hydroxymandelic acid and 3-methoxy-4-hydroxyphenylacetic acid by 288 patients with neuroblastoma and related neural crest tumors.
LaBrosse EH; Com-Nougué C; Zucker JM; Comoy E; Bohuon C; Lemerle J; Schweisguth O
Cancer Res; 1980 Jun; 40(6):1995-2001. PubMed ID: 7371035
[No Abstract] [Full Text] [Related]
16. Biochemical and histologic determinants in the prognosis of neuroblastoma.
Gitlow SE; Dziedzic LB; Strauss L; Greenwood SM; Dziedzic SW
Cancer; 1973 Oct; 32(4):898-905. PubMed ID: 4751920
[No Abstract] [Full Text] [Related]
17. Olive ingestion causing a false suspicion of relapsed neuroblastoma: A case of "oliveblastoma?".
Flynn N; LeFebvre A; Messahel B; Hogg SL
Pediatr Blood Cancer; 2018 Oct; 65(10):e27248. PubMed ID: 29923309
[TBL] [Abstract][Full Text] [Related]
18. More on gas-liquid chromatographic determination of homovanillic and vanillylmandelic acids in urine from cases of neuroblastoma.
Melchert HU; Hoffmeister H
Clin Chem; 1978 May; 24(5):842-3. PubMed ID: 647929
[No Abstract] [Full Text] [Related]
19. Mass screening for neuroblastoma in infants.
Wei M; Ye M; Dong K; Dong R
Discov Med; 2020; 30(160):63-70. PubMed ID: 33382962
[TBL] [Abstract][Full Text] [Related]
20. Results of mass screening for neuroblastoma in Sapporo, Japan.
Takeda T; Nishi M; Shimada M; Nakadate H; Hatae Y; Naito H; Hanai J; Kawai T; Takasugi N
Prog Clin Biol Res; 1991; 366():595-601. PubMed ID: 2068178
[No Abstract] [Full Text] [Related]
[Next] [New Search]
